| Plotted Points Statistics |
| 11-KETOTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 38 | 90% | 19% | 88% | 15% |
| Total | 38 | 90% | 19% | 88% | 15% |
| Sample Statistics |
| 11-KETOTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 38 | 81% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 5 | 11% | Spiked |
| Spiked | 47 | . | |
| False Negatives | 4 | 9% | 4 out of 47 |
| Not Spiked | 69 | . | |
| False Positives | 0 | 0% | 0 out of 69 |
| Plotted Points Statistics |
| 17-ALPHA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 68 | 87% | 26% | 84% | 13% |
| Total | 68 | 87% | 26% | 84% | 13% |
| Sample Statistics |
| 17-ALPHA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 68 | 89% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 4% | Spiked |
| Spiked | 76 | . | |
| False Negatives | 5 | 7% | 5 out of 76 |
| Not Spiked | 40 | . | |
| False Positives | 1 | 3% | 1 out of 40 |
| Plotted Points Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 58 | 80% | 17% | 78% | 15% |
| Total | 58 | 80% | 17% | 78% | 15% |
| Sample Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 58 | 76% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 76 | . | |
| False Negatives | 18 | 24% | 18 out of 76 |
| Not Spiked | 40 | . | |
| False Positives | 2 | 5% | 2 out of 40 |
| Plotted Points Statistics |
| 17-BETA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 54 | 78% | 12% | 79% | 9% |
| Total | 54 | 78% | 12% | 79% | 9% |
| Sample Statistics |
| 17-BETA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 54 | 78% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 69 | . | |
| False Negatives | 14 | 20% | 14 out of 69 |
| Not Spiked | 39 | . | |
| False Positives | 1 | 3% | 1 out of 39 |
| Plotted Points Statistics |
| 3-BETA-COPROSTANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 30 | 70% | 20% | 62% | 21% |
| Total | 30 | 70% | 20% | 62% | 21% |
| Sample Statistics |
| 3-BETA-COPROSTANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 30 | 65% | Spiked |
| Estimated Values | 2 | 4% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 47 | . | |
| False Negatives | 16 | 35% | 16 out of 46 |
| Not Spiked | 25 | . | |
| False Positives | 0 | 0% | 0 out of 25 |
| Plotted Points Statistics |
| 4,4^-BISPHENOL F |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 32 | 85% | 30% | 80% | 28% |
| Total | 32 | 85% | 30% | 80% | 28% |
| Sample Statistics |
| 4,4^-BISPHENOL F |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 32 | 100% | Spiked |
| Estimated Values | 32 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 32 | . | |
| False Negatives | 0 | 0% | 0 out of 32 |
| Not Spiked | 61 | . | |
| False Positives | 0 | 0% | 0 out of 61 |
| Plotted Points Statistics |
| 4,4^-BISPHENOL F, WU |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 32 | 85% | 30% | 80% | 28% |
| Total | 32 | 85% | 30% | 80% | 28% |
| Sample Statistics |
| 4,4^-BISPHENOL F, WU |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 32 | 100% | Spiked |
| Estimated Values | 32 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 32 | . | |
| False Negatives | 0 | 0% | 0 out of 32 |
| Not Spiked | 61 | . | |
| False Positives | 0 | 0% | 0 out of 61 |
| Sample Statistics |
| 4,4^-BISPHENOL S |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 0 | . | Spiked |
| Estimated Values | 0 | . | Spiked |
| Deleted Values | 4 | 100% | Spiked + Not Spiked |
| Spiked, Censored | 0 | . | Spiked |
| Spiked | 0 | . | |
| False Negatives | 0 | . | 0 out of 0 |
| Not Spiked | 4 | . | |
| False Positives | 0 | . | 0 out of 0 |
| Plotted Points Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 28 | 61% | 27% | 56% | 20% |
| Total | 28 | 61% | 27% | 56% | 20% |
| Sample Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 28 | 64% | Spiked |
| Estimated Values | 1 | 2% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 8 | 18% | Spiked |
| Spiked | 44 | . | |
| False Negatives | 8 | 18% | 8 out of 44 |
| Not Spiked | 72 | . | |
| False Positives | 1 | 1% | 1 out of 72 |
| Plotted Points Statistics |
| BISPHENOL A |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 40 | 79% | 24% | 80% | 26% |
| Total | 40 | 79% | 24% | 80% | 26% |
| Sample Statistics |
| BISPHENOL A |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 40 | 95% | Spiked |
| Estimated Values | 27 | 64% | Spiked |
| Deleted Values | 2 | 3% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 43 | . | |
| False Negatives | 2 | 5% | 2 out of 42 |
| Not Spiked | 29 | . | |
| False Positives | 0 | 0% | 0 out of 28 |
| Plotted Points Statistics |
| CHOLESTEROL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 42 | 81% | 20% | 75% | 15% |
| Total | 42 | 81% | 20% | 75% | 15% |
| Sample Statistics |
| CHOLESTEROL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 42 | 93% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 46 | . | |
| False Negatives | 3 | 7% | 3 out of 45 |
| Not Spiked | 26 | . | |
| False Positives | 2 | 8% | 2 out of 26 |
| Plotted Points Statistics |
| CIS-ANDROSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 63% | 8% | 61% | 11% |
| >= Reporting Level | 57 | 69% | 18% | 66% | 21% |
| Total | 60 | 69% | 18% | 66% | 20% |
| Sample Statistics |
| CIS-ANDROSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 60 | 81% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 5 | 7% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 9 | 12% | 9 out of 74 |
| Not Spiked | 42 | . | |
| False Positives | 1 | 2% | 1 out of 42 |
| Plotted Points Statistics |
| DIHYDROTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 49 | 71% | 18% | 73% | 13% |
| Total | 49 | 71% | 18% | 73% | 13% |
| Sample Statistics |
| DIHYDROTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 49 | 79% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 5% | Spiked |
| Spiked | 62 | . | |
| False Negatives | 10 | 16% | 10 out of 62 |
| Not Spiked | 54 | . | |
| False Positives | 1 | 2% | 1 out of 54 |
| Plotted Points Statistics |
| EPITESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 60 | 70% | 18% | 68% | 11% |
| Total | 60 | 70% | 18% | 68% | 11% |
| Sample Statistics |
| EPITESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 60 | 90% | Spiked |
| Estimated Values | 4 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 67 | . | |
| False Negatives | 7 | 10% | 7 out of 67 |
| Not Spiked | 49 | . | |
| False Positives | 0 | 0% | 0 out of 49 |
| Plotted Points Statistics |
| EQUILENIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 44 | 95% | 37% | 102% | 43% |
| Total | 44 | 95% | 37% | 102% | 43% |
| Sample Statistics |
| EQUILENIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 44 | 100% | Spiked |
| Estimated Values | 3 | 7% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 44 | . | |
| False Negatives | 0 | 0% | 0 out of 44 |
| Not Spiked | 27 | . | |
| False Positives | 0 | 0% | 0 out of 27 |
| Plotted Points Statistics |
| EQUILIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 63 | 63% | 20% | 61% | 16% |
| Total | 63 | 63% | 20% | 61% | 16% |
| Sample Statistics |
| EQUILIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 63 | 85% | Spiked |
| Estimated Values | 63 | 85% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 74 | . | |
| False Negatives | 11 | 15% | 11 out of 74 |
| Not Spiked | 42 | . | |
| False Positives | 0 | 0% | 0 out of 42 |
| Plotted Points Statistics |
| ESTRIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 69 | 80% | 16% | 81% | 16% |
| Total | 69 | 80% | 16% | 81% | 16% |
| Sample Statistics |
| ESTRIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 69 | 91% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 76 | . | |
| False Negatives | 6 | 8% | 6 out of 76 |
| Not Spiked | 40 | . | |
| False Positives | 0 | 0% | 0 out of 40 |
| Plotted Points Statistics |
| ESTRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 59 | 71% | 17% | 68% | 15% |
| Total | 59 | 71% | 17% | 68% | 15% |
| Sample Statistics |
| ESTRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 59 | 73% | Spiked |
| Estimated Values | 5 | 6% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 6 | 7% | Spiked |
| Spiked | 81 | . | |
| False Negatives | 16 | 20% | 16 out of 81 |
| Not Spiked | 35 | . | |
| False Positives | 0 | 0% | 0 out of 34 |
| Plotted Points Statistics |
| MESTRANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 35 | 48% | 22% | 44% | 14% |
| Total | 35 | 48% | 22% | 44% | 14% |
| Sample Statistics |
| MESTRANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 47% | Spiked |
| Estimated Values | 2 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 4% | Spiked |
| Spiked | 75 | . | |
| False Negatives | 37 | 49% | 37 out of 75 |
| Not Spiked | 38 | . | |
| False Positives | 2 | 5% | 2 out of 38 |
| Plotted Points Statistics |
| NORETHINDRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 53 | 80% | 19% | 78% | 15% |
| Total | 53 | 80% | 19% | 78% | 15% |
| Sample Statistics |
| NORETHINDRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 53 | 70% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 4% | Spiked |
| Spiked | 76 | . | |
| False Negatives | 20 | 26% | 20 out of 76 |
| Not Spiked | 40 | . | |
| False Positives | 0 | 0% | 0 out of 40 |
| Plotted Points Statistics |
| PROGESTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 64 | 40% | 12% | 38% | 11% |
| Total | 64 | 40% | 12% | 38% | 11% |
| Sample Statistics |
| PROGESTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 64 | 82% | Spiked |
| Estimated Values | 64 | 82% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 78 | . | |
| False Negatives | 14 | 18% | 14 out of 78 |
| Not Spiked | 38 | . | |
| False Positives | 0 | 0% | 0 out of 38 |
| Plotted Points Statistics |
| TESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 57 | 73% | 13% | 73% | 13% |
| Total | 57 | 73% | 13% | 73% | 13% |
| Sample Statistics |
| TESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 57 | 84% | Spiked |
| Estimated Values | 1 | 1% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 1% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 10 | 15% | 10 out of 68 |
| Not Spiked | 45 | . | |
| False Positives | 2 | 4% | 2 out of 45 |